Radioiodine for Graves’ Disease Therapy
Radioiodine-131 (RAI) is an isotope of the chemical element iodine and is commonly used for hyperthyroidism, including Graves’ disease. It is given orally, and its concentration in the thyroid gland. The RAI transport involves a natrium iodide symporter (NIS) role that brings two cations sodium (Na+...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/75915 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Radioiodine for Graves’ Disease Therapy
- Aspects Considered in Differentiated Thyroid Cancer for Radioiodine Therapy
- Radioiodine Treatment for Hyperthyroid Graves’ Disease
- Hypothyroidism and Radioiodine Therapy
- Radiopharmaceuticals in Modern Cancer Therapy
- The Molecular Basis for Radioiodine Therapy
- Preparing Patients for Radioiodine Treatment: Increasing Thyroid Cell Uptake and Accelerating the Excretion of Unbound Radioiodine